Latest Intelligence in South and Central America

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

An opportunity in Brazil: local hedge funds

The average Brazilian HNW investment portfolio has almost a quarter of its funds in alternative investments, with the popularity of the local hedge fund market a major motivation. The funds are more strongly regulated than their European equivalents and demand greater regulatory compliance, but this burden should not discourage foreign firms, given the demand for such products.

Published By Datamonitor
30 Nov 2012
Expert View
Expert View

Ancient grains stage a revival in the packaged food industry

Packaged food and beverage markets are seeing a growing influx of new products featuring grains that were favored by civilizations thousands of years ago. According to Datamonitor's Productscan Online database of new products, new food and beverage launches featuring a short list of ancient grains, including chia, have doubled since 2005 as manufacturers jump on the latest health food band wagon.

Published By Datamonitor
07 May 2008
ResearchWire
ResearchWire

Antiarrhythmics market: new product launches to reinvigorate growth

Published By Datamonitor
21 Jul 2006
ResearchWire
ResearchWire

Antihypertensives: ARBs at the heart of the market

Published By Datamonitor
27 Mar 2006
ResearchWire
ResearchWire

Antihypertensives: mature pipeline reflects market

Published By Datamonitor
01 Aug 2007
ResearchWire
ResearchWire

Antithrombotic market: novel agents will dampen generic incursion

Published By Datamonitor
15 Jan 2007
ResearchWire
ResearchWire

Antithrombotics: blockbuster potential for novel anticoagulants

Published By Datamonitor
31 May 2007
ResearchWire
ResearchWire

Anxiety disorders: global sales set to slide

Published By Datamonitor
03 May 2006
CommentWire
CommentWire

AP Moller-Maersk: delivering a mixed bag

Shipping company AP Moller-Maersk has released its results for 2006. Although overall revenue increased, profitability collapsed due to its container business unit suffering from over-supply in the industry. While the company forecasted a positive picture for 2007, further diversification may be required.

Published By Datamonitor
30 Mar 2007
CommentWire
CommentWire

APA 2010: Alkermes prepares to enter potentially lucrative opioid dependence market

At this year's American Psychiatric Association meeting, US pharmaceutical company Alkermes presented promising new data for Vivitrol in the treatment of opioid dependence. The FDA is currently assessing the drug under a priority review, and approval in the burgeoning opioid dependence indication would be a major boon for Alkermes.

Published By Datamonitor
10 Jun 2010

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.